Department of Maternal-Fetal Medicine, ICGON, Hospital Clínic, University of Barcelona and Centre for Biomedical Research on Rare Diseases (CIBERER), 08028 Barcelona, Spain.
Contraception. 2010 Feb;81(2):97-101. doi: 10.1016/j.contraception.2009.10.001. Epub 2009 Nov 12.
This study was conducted to explore the effect of gestational age (GA) on the induction-to-abortion interval of mifepristone-misoprostol midtrimester termination of pregnancy (TOP) regimen.
This study involved a consecutive series of 270 pregnancies between 12.0 and 22.6 weeks that have undergone legal TOP from April 2006 to June 2009. All women received a single oral dose of 200 mg mifepristone and, 36-48 h later, a course of misoprostol (an initial vaginal dose of 800 mcg plus four oral doses of 400 mcg at 3-hourly intervals). Treatment was considered to be a failure if abortion did not occur within 24 h. The impact of GA, parity and maternal age on the induction-to-abortion interval was assessed by means of Cox regression.
Overall, the mean GA at TOP was 18.0 weeks. The mean induction-to-abortion interval was 9.8 h (SD=8.2 h; range=1-50 h), and 246 women (91%) aborted successfully within 24 h. GA at TOP and parity were the only two variables independently associated with the induction-to-abortion interval. The mean induction-to-abortion interval was increased by about 50% in patients undergoing TOP between 20.0 and 22.6 weeks (12.9 h, SD=8.9), as compared with those at 16.0-19.6 weeks (7.8 h, SD=5.9) and 12.0-15.6 weeks (8.2 h, SD=8.3) (p<.001). The effect of parity on the induction-to-abortion interval was more modest, with a 20% increase in induction-to-abortion interval in nulliparous (10.1 h, SD=9.1), as compared with women with a previous live birth (8.1 h, SD=6.7).
The mean induction-to-abortion interval increases by 4 h after 20 weeks GA. This information may be relevant for counseling and planning of the procedure.
本研究旨在探讨孕龄(GA)对米非司酮-米索前列醇中期妊娠终止(TOP)方案诱导至流产间隔的影响。
本研究为 2006 年 4 月至 2009 年 6 月期间连续进行的 270 例 12.0 至 22.6 周合法 TOP 的妊娠病例系列。所有女性均接受单次口服米非司酮 200mg,36-48 小时后给予米索前列醇(初始阴道剂量 800μg,4 小时后口服 400μg,共 4 次)。如果 24 小时内未发生流产,则认为治疗失败。采用 Cox 回归评估 GA、产次和产妇年龄对诱导至流产间隔的影响。
总体而言,TOP 的平均 GA 为 18.0 周。平均诱导至流产间隔为 9.8 小时(SD=8.2 小时;范围 1-50 小时),246 名(91%)妇女在 24 小时内成功流产。TOP 时的 GA 和产次是与诱导至流产间隔独立相关的两个唯一变量。在 20.0 至 22.6 周(12.9 小时,SD=8.9)接受 TOP 的患者中,诱导至流产间隔增加约 50%,而在 16.0-19.6 周(7.8 小时,SD=5.9)和 12.0-15.6 周(8.2 小时,SD=8.3)的患者中则降低(p<.001)。产次对诱导至流产间隔的影响较小,初产妇(10.1 小时,SD=9.1)的诱导至流产间隔比经产妇(8.1 小时,SD=6.7)增加 20%。
GA 超过 20 周后,平均诱导至流产间隔增加 4 小时。这些信息可能与咨询和手术计划相关。